Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Reexamination Certificate
2006-12-22
2010-02-16
Desai, Anand U (Department: 1656)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
C514S002600
Reexamination Certificate
active
07662389
ABSTRACT:
The present invention provides compositions and methods for treating glaucoma, methods for diagnosing glaucoma, and methods for identifying agents which may be useful in the treatment of glaucoma. More specifically, the present invention describes the use of agents that modulate the expression of serum amyloid A.
REFERENCES:
patent: 4656127 (1987-04-01), Mundy
patent: 4998617 (1991-03-01), Ladd, Jr. et al.
patent: 5459039 (1995-10-01), Modrich et al.
patent: 5545628 (1996-08-01), Deboeck et al.
patent: 5593826 (1997-01-01), Fung et al.
patent: 6433018 (2002-08-01), Siddiqui et al.
patent: 7357931 (2008-04-01), Clark et al.
patent: 2002/0102581 (2002-08-01), Hageman et al.
patent: 2003/0078274 (2003-04-01), Lipton
patent: 1 196 167 (2006-04-01), None
patent: 2650840 (1989-08-01), None
patent: WO 91/02087 (1991-02-01), None
patent: WO 92/15712 (1992-09-01), None
patent: WO 94/16101 (1994-07-01), None
patent: WO 94/16101 (1994-07-01), None
patent: WO 2005/060542 (2005-07-01), None
patent: WO 2005/060542 (2005-07-01), None
Barany, Proc. Natl. Acad. Sci. USA 88:189-193 (1991); “Genetic disease detection and DNA amplification using cloned thermostable ligase”.
Bengtsson, “Incidence of manifest glaucoma,” Br J Ophthalmol, vol. 73, pp. 483-487 (1989).
Cotton et al., Proc. Natl. Acad. Sci. USA 85:4397 (1988); “Reactivity of cytosine and thymine in single-base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations”.
Cotton, Mutat. Res. 285:125-144 (1993); “Current methods of mutation detection”.
Cronin et al. , Human Mutation 7:244-255 (1996); “Cystic Fibrosis Mutation Detection by Hybridization to Light-Generated DNA Probe Arrays”.
Ermilov et al. (1993); Arkh Patol.; “Senile amyloidosis of the eye as a manifestation of senile cerebral amyloidosis” [abstract] with article in Russian 55(6):43-45.
Furlenato, CJ, and Campa A, Biochem. Biophys. Res. Commun 268:405-408 (2002), “A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 by human blood neutrophil”.
Gasparini et al. , Mol. Cell Probes 6:1-7 (1992); “Restriction site generating-polymerase chain reaction (RG-PCR) for the probeless detection of hidden genetic variation: application to the study of some common cystic fibrosis mutations”.
Gibbs et al., Nucleic Acids Res. 17:2437-2448 (1989); “Detection of single DNA base differences by competitive oligonucleotide priming”.
Griffin et al., Appl. Biochem Biotechnol. 38:147-159 (1993); “DNA Sequencing Recent Innovations and Future Trends”.
Guatelli, J. C., et al., Proc. Natl. Acad. Sci. USA 87:1874-1878 (1990); “Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication”.
Hagihara K et al, 2004, Biochemical and Biophysical Research Communications, “IL-6 plays a critical role in the synergistic induction of human serum Amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analysed with an SAA isoform real-time quantitative RT-PCR assay system”, 314, 363-369.
Hayashi, Genet. Anal. Tech. Appl. 9:73-79 (1992); “PCR-SSCP: A Method for Detection of Mutations”.
He, R, Sang H, Ye, RD, Serum Amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R, Blood 101:1572-1581 (2003).
Hsu et al., Carcinogenesis 15:1657-1662(1994); “Detection of DNA point mutations with DNA mismatch repair enzymes”.
Krasnov et al. (Jan.-Mar. 1996); Vestn Oftalmol, “Morphological features of senile and secondary amyloidosis of the iris and sclera in patients with glaucoma” [abstract] with article will be in Russian 12(1):24-6.
Kumon, Y. et al, Acute-phase, but not constitutive serum amyloid A (SAA) is chemotactic for cultured human aortic smooth muscle cells, AMYLOID 9:237-241 (2002a).
Kumon Y. et al., Transcriptional regulation of Serum Amyloid A1 gene expression in human aortic smooth muscle cells involves CCAAT/enhancer binding proteins (C/EBP) and is distinct from HepG2 cells,, Scand. J. Immunol. 56:504-511 (2002b).
Kumon, Y. et al., Dexamethasone, but not IL-1 alone, upregulates acute-phase serum amyloid A gene expression and production by cultured human aortic smooth muscle cells, Scand J. Immunol. 53:7-12 (2001).
Kuppuswamy, M. N. et al. Proc. Natl. Acad. Sci. (U.S.A.) 88:1143-1147 (1991); “Single nucleotide primer extension to detect genetic diseases: Experimental application to hemophilia B (factor IX) and cystic fibrosis genes”.
Kwoh, D. Y., et al., Proc. Natl. Acad. Sci. USA 86:1173-1177 (1989); “Transcription-based amplification system and detection of amplified human immunodeficiency virus type 1 with a bead-based sandwich hybridization format”.
Landegren, U. et al., Science 241:1077:1080 (1988); “A Ligase-Mediated Gene Detection Technique”.
Liang, J.S., Sloane, J.A., Wells, J.M., Abraham, C.R., Fine, R.E., and Sipe, J.D., Evidence for local production of acute phase response apolipoprotein serum amyloid A in Alzheimer's disease brain, Neurosci. Lett. 225:73-76 (1997).
Lizardi, P. M. et al., Bio/Technology 6:1197-1202 (1988); “Exponential Amplification of Recombinant-RNA Hybridization Probes”.
Maxam and Gilbert, Proc. Natl. Acad. Sci. USA 74:560 (1977); “A new method for sequencing DNA”.
Miida T., Yamada, T., Yamadera, T., Ozaki, K., Inano, K., Okada, M., Serum amyloid A protein generates pre-beta 1 high-density lipoprotein from alpha-migrating high-density lipoprotein, Biochem. 38(51):16958-16962 (1999).
Myers et al., Nature 313:495 (1985a); “Detection of singie base substitutions in total genomic DNA”.
Myers et al., Science 230:1242 (1985b); “Detection of Single Base Substitutions by Ribonuclease Cleavage at Mismatches in RNA:DNA Duplexes”.
Nickerson, D. A. et al., Proc. Natl. Acad. Sci. USA 87:8923-27 (1990); “Automated DNA diagnostics using an ELISA-based oligonucleotide ligation assay”.
O'Hara, R., Murphy, E.P., Whitehead, A.S., FitzGerald, O., and Bresnihan, B., Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue, Arthritis Res. 2:142-148 (2000).
Orita et al., Proc. Natl. Acad. Sci. USA 86:2766 (1989); “Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms”.
PCT International Search Report of a related PCT Application No. PCT/US04/40156, mailed Jul. 26, 2006.
Prosser, Tibtech 11:238 (1993): “Detecting single-base mutations”.
Roest et al., Hum. Mol. Genet. 2:1717-1721 (1993); “Protein truncation test (PTT) for rapid detection of translation-terminating mutations”.
Saiki et al., Nature 324:163-166 (1986); “Analysis of enzymatically amplified •-globin and HLA-DQ• DNA with allele-specific oligonucleotide probes”.
Saiki et al., Proc. Natl. Acad. Sci. USA 86:6230-6234 (1989); “Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes”.
Sanger et al. Proc. Natl. Acad. Sci. USA 74:5463 (1977); “DNA sequencing with chain-terminating inhibitors”.
Schwartz et al. (1982); Ophthalmology, 89(4):394-401Sokolov, B.P., Nucl. Acids Res. 18:3671 (1990); “Primer extension technique for the detection of single nucleotide in genomic DNA”.
Sokolov, B.P., Nucl. Acids Res. 18:3671 (1990); “Primer extension technique for the detection of single nucleotide in genomic DNA”.
Strong, N. P., “How optometrists screen for glaucoma: A survey”, Ophthal. Physiol. Opt., 12:3-7 (1992).
Syvanen, A. -C., et al., Genomics 8:684-692 (1990); “A Primer-Guided Nucleotide Incorporation Assay in the Genotyping of Apolipoprotein E”.
Thorn, C.F. and Whitehead, A.S., Differential glucocorticoid enhancement of the cytokine-driven transcriptional acti
Clark Abbot F.
McNatt Loretta Graves
Wang Wan-Heng
Alcon Inc.
Desai Anand U
Schultz Teresa J.
LandOfFree
Use of serum amyloid A gene in diagnosis and treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of serum amyloid A gene in diagnosis and treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of serum amyloid A gene in diagnosis and treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4208656